A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT

PHASE2UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

September 30, 2014

Conditions

Steroid-refractory Bronchiolitis Obliterans

Interventions

DRUG

Interferon gamma 1b

Initial dose: 50µg s.c. three times/week, without fever \>38,5 dose increase: 50µg/m² BSA three times/week

Trial Locations (1)

University Hospital Regensburg, Regensburg